John Kurhanewicz, PhD
|School||UCSF School of Medicine|
|Department||Radiology and Biomedical Imaging|
|Address||1700 4th Street|
San Francisco CA 94158
|Academy of Radiology Research ||2013||Distinguished Investigator |
|International Society for Magnetic Resonance in Medicine||2009||GE Healthcare’s MR Thought Leader|
|University of California, San Francisco School of Pharmacy||2009||Dean’s Recognition for Excellence in Teaching |
|Society of Magnetic Resonance in Medicine||2008||Fellow|
|International Society for Magnetic Resonance in Medicine||2007
||2008||Outstanding Teacher Award|
|University of South Florida||1998||Outstanding Chemistry Alumnus |
John Kurhanewicz, PhD, is a Professor in Residence of Radiology, Urology and Pharmaceutical Chemistry. He is the Director of the Body Imaging Research Group, Director of the Body Research Interest Group, and Direct of Kurhanewicz Laboratory at the University of California, San Francisco. Dr. Kurhanewicz is recognized internationally for his research in magnetic resonance imaging and spectroscopic imaging of patients with prostate cancer, and he is involved in the development and translation of this technology into the clinic. Dr. Kurhanewicz received his BS in Chemistry from the University of South Florida/New College in 1982, and obtained his PhD in Physical Chemistry from the University of South Florida, Tampa in 1987, followed by a postdoctoral fellowship in MRI/MRS from the University of California, San Francisco in 1990.
Accurate characterization of prostate cancer has become a major problem and Dr. Kurhanewicz and his colleagues have developed a program with new anatomic and metabolic MR spectroscopic imaging methods to provide an improved assessment of prostate cancer for individual patients. Dr. Kurhanewicz is involved in the development and clinical translation of an extraordinary new molecular imaging technique utilizing hyperpolarized 13C labeled metabolic substrates that has the potential to revolutionize the way we use MR imaging in the risk assessment of prostate cancer patients.
Dr. Kurhanezwicz has served as a scientific reviewer for over 20 different journals. He is a member of 7 societies and groups, he has served as grant reviewer for over 20 organizations, and presently serves on several departmental committees. Dr. Kurhanezwicz has 169 published articles and he has written 196 peer-reviewed articles, 19 book chapters, and 352 abstracts.
Prostate cancer, urology, pharmaceutical chemistry
Magnetic resonance imaging, magnetic resonance spectroscopy, hyperpolarized 13C MR cancer, dynamic nuclear polarization, hyperpolarized probes, micro-imaging, diffusion tensor imaging, dynamic contrast enhanced imaging, prostate cancer, imaging biomarkers, high-resolution magic angle spinning (HR-MAS) spectroscopy, 13C and 31P spectroscopy, immunohistochemistry, gene expression, clinical translation
Education and Training:
• Bachelor of Science: University of South Florida/New College - BS, Chemistry
• Doctor of Philosophy: University of South Florida, Tampa - Physical Chemistry
• Postdoctoral Fellowship: University of California, San Francisco - Vivo MRI/MRS
Magnetic resonance imaging, magnetic resonance spectroscopy, hyperpolarized 13C MR cancer, dynamic nuclear polarization, hyperpolarized probes, micro-imaging, diffusion tensor imaging, dynamic contrast enhanced imaging, prostate cancer, imaging biomarkers, high-resolution magic angle spinning (HR-MAS) spectroscopy, 13C and 31P spectroscopy, immunohistochemistry, gene expression, clinical translation.
Click the "See All" links for more information and interactive visualizations!
Derived automatically from this person's publications.
People in Profiles who have published with this person.
People who share related concepts with this person.